AU-15330

N/A

Report date: 2022/12/27 18:19:59

Base Information

Drug NameAU-15330
Drug Alias NameAU-15330
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProbable global transcription activator SNF2L2 inhibitorsSMARCA4 inhibitors
TargetsTranscription activator BRG1Probable global transcription activator SNF2L2
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurigene
China Registration ClassN/A

Develop Information

Active CompaniesAurigene
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A